TP53 and acute myeloid leukemia: Notably, there is evidence that a similar proportion of AML patients with complex karyotypes and poor prognoses tend to possess TP53 alterations (~70%) [38], and these patients also possess similar CN alterations, including -5/5q-, -7/7q-, -18/18q-, and +11/+11q/amp11q13∼25.